Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Induced Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03806556
What this trial is testing

A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

Who this might be right for
Pediatric CancerThrombocytopeniaHemostatic Disorder+1 more
Meghan McCormick 11
Testing effectiveness (Phase 2)Ended earlyNCT00886743
What this trial is testing

Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia

Who this might be right for
Severe Thrombocytopenia
Pfizer 19
Testing effectiveness (Phase 2)Study completedNCT01147809
What this trial is testing

Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 130
Testing effectiveness (Phase 2)UnknownNCT02781155
What this trial is testing

Limiting Chemotherapy Side Effects by Using Moxa

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsGenital Neoplasms, Female+1 more
East and North Hertfordshire NHS Trust 25
Large-scale testing (Phase 3)Study completedNCT05851027
What this trial is testing

Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 50
Not applicableNot Yet RecruitingNCT07575854
What this trial is testing

Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal Cancer

Who this might be right for
Gastrointestinal Cancer
Centre Georges Francois Leclerc 18
Testing effectiveness (Phase 2)Looking for participantsNCT07586813
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGastrointestinal Neoplasms+2 more
Peking University People's Hospital 220
Testing effectiveness (Phase 2)Ended earlyNCT02227576
What this trial is testing

Prevention of Thrombocytopenia in Glioblastoma Patients

Who this might be right for
ThrombocytopeniaGlioblastoma
University Hospital, Lille 20
Large-scale testing (Phase 3)WithdrawnNCT05261646
What this trial is testing

A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT05554913
What this trial is testing

Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 63
Large-scale testing (Phase 3)Active Not RecruitingNCT05864014
What this trial is testing

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 213
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07647029
What this trial is testing

A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae

Who this might be right for
Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT)
Fudan University 126
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07252375
What this trial is testing

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)CTIT-Chemotherapy Induced Thrombocytopenia
Fujian Cancer Hospital 35
Testing effectiveness (Phase 2)UnknownNCT05252091
What this trial is testing

An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Henan Cancer Hospital 30
Large-scale testing (Phase 3)Study completedNCT03976882
What this trial is testing

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 129
Large-scale testing (Phase 3)UnknownNCT02093325
What this trial is testing

Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia

Who this might be right for
Solid Tumor
Chang Gung Memorial Hospital 83
Early research (Phase 1)Study completedNCT00442871
What this trial is testing

Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 29
Testing effectiveness (Phase 2)Study completedNCT04673266
What this trial is testing

Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma

Who this might be right for
Lymphoma PatientsThrombocytopenia
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00283439
What this trial is testing

A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma

Who this might be right for
Chemotherapy-Induced ThrombocytopeniaHodgkin's LymphomaNon-Hodgkin's Lymphoma+3 more
Amgen 39
Large-scale testing (Phase 3)UnknownNCT02244658
What this trial is testing

Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia

Who this might be right for
Antineoplastic Adverse ReactionThrombocytopeniaAcute Myelocytic Leukemia
Shandong University 80
Next Page